Apg Asset Management N.V. Jazz Pharmaceuticals PLC Transaction History

Apg Asset Management N.V.

$61 Billion
Q1 2024

A detailed history of Apg Asset Management N.V. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Apg Asset Management N.V. holds 77,132 shares of JAZZ stock, worth $8.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

77,132

Previous 46,508 65.85%

Holding current value

$8.11 Million

Previous $5.72 Million 62.38%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $3.53 Million - $4.07 Million	30,624 Added 65.85%	77,132 $9.29 Million
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $7.02 Million - $8.35 Million	-61,423 Reduced 56.91%	46,508 $5.72 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $2.97 Million - $3.54 Million	24,376 Added 29.17%	107,931 $14 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $1.46 Million - $1.76 Million	11,947 Added 16.68%	83,555 $10.4 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $853,184 - $1.02 Million	-6,368 Reduced 8.17%	71,608 $10.5 Million

Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $7.1 Million - $8.75 Million	54,708 Added 235.12%	77,976 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.92 Million - $2.44 Million	15,169 Added 187.29%	23,268 $3.17 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $707,100 - $842,288	4,994 Added 160.84%	8,099 $1.21 Million
Q1 2022 May 12, 2022	SELL	$129.64 - $160.7 $64,819 - $80,350	-500 Reduced 13.87%	3,105 $434,000
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $95,896 - $116,535	-800 Reduced 18.16%	3,605 $404,000
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $5.76 Million - $8.28 Million	-44,813 Reduced 91.05%	4,405 $495,000
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $897,119 - $1.04 Million	-5,600 Reduced 10.22%	49,218 $7.37 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $184,583 - $213,231	-1,229 Reduced 2.19%	54,818 $7.67 Million
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $2.74 Million - $3.22 Million	-19,483 Reduced 25.8%	56,047 $7.56 Million
Q3 2020 Nov 12, 2020	BUY	$105.46 - $144.13 $1.14 Million - $1.56 Million	10,809 Added 16.7%	75,530 $9.18 Million
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $392,288 - $499,708	-4,100 Reduced 5.96%	64,721 $6.36 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $26.3 Million - $45.9 Million	-300,230 Reduced 81.35%	68,821 $6.86 Million
Q1 2020 May 14, 2020	BUY	$87.74 - $152.74 $28.2 Million - $49 Million	320,985 Added 667.8%	369,051 $47 Million
Q3 2019 Nov 08, 2019	BUY	$125.18 - $143.24 $3.59 Million - $4.11 Million	28,715 Added 148.39%	48,066 $5.65 Million
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $43.9 Million - $50.5 Million	-349,700 Reduced 94.76%	19,351 $2.42 Million
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $25.4 Million - $29.8 Million	-208,203 Reduced 36.07%	369,051 $47 Million
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $18.3 Million - $26.3 Million	157,800 Added 37.62%	577,254 $62.6 Million
Q3 2018 Nov 09, 2018	BUY	$161.01 - $180.57 $3.8 Million - $4.26 Million	23,600 Added 5.96%	419,454 $60.7 Million
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $2.78 Million - $3.48 Million	-19,000 Reduced 4.58%	395,854 $58.4 Million
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $420,329 - $487,196	3,100 Added 0.75%	414,854 $50.9 Million
Q4 2017 Jan 24, 2018	BUY	$131.06 - $150.39 $7.4 Million - $8.5 Million	56,495 Added 15.9%	411,754 $46.2 Million
Q3 2017 Oct 19, 2017	BUY	$142.62 - $155.6 $50.7 Million - $55.3 Million	355,259	355,259 $52 Million

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57M

Call Options Held

65.9K

Put Options Held

183K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.59B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Jazz Pharmaceuticals PLC Transaction History